4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-22-000047
SVP Corporate Development returned 1,615 shares (to the company)
- SVP Corporate Development acquired 2,889 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dolan Matthew Vincent SVP Corporate Development | 2022-03-08 | Grant or award | +2,889 | $0.00 | $3 | 10,435 | D: show line 1 in the form |
| Dolan Matthew Vincent SVP Corporate Development | 2022-03-09 | Returned to the company | −393 | $406.06 | $159,580 | 10,042 | D: show line 2 in the form |
| Dolan Matthew Vincent SVP Corporate Development | 2022-03-09 | Returned to the company | −192 | $406.06 | $77,963 | 9,850 | D: show line 3 in the form |
| Dolan Matthew Vincent SVP Corporate Development | 2022-03-09 | Returned to the company | −489 | $406.06 | $198,562 | 9,361 | D: show line 4 in the form |
| Dolan Matthew Vincent SVP Corporate Development | 2022-03-09 | Returned to the company | −541 | $406.06 | $219,677 | 8,820 | D: show line 5 in the form |
Loading xslF345X03/edgardoc.xml…